184 related articles for article (PubMed ID: 31943120)
1. Adult haemophagocytic lymphohistiocytosis: a Review.
Yildiz H; Van Den Neste E; Defour JP; Danse E; Yombi JC
QJM; 2020 Jan; ():. PubMed ID: 31943120
[TBL] [Abstract][Full Text] [Related]
2. Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies.
Yildiz H; Bailly S; Van Den Neste E; Yombi JC
Ther Clin Risk Manag; 2021; 17():293-304. PubMed ID: 33888986
[TBL] [Abstract][Full Text] [Related]
3. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
Summerlin J; Wells DA; Anderson MK; Halford Z
Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
[TBL] [Abstract][Full Text] [Related]
4. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Ahmed A; Merrill SA; Alsawah F; Bockenstedt P; Campagnaro E; Devata S; Gitlin SD; Kaminski M; Cusick A; Phillips T; Sood S; Talpaz M; Quiery A; Boonstra PS; Wilcox RA
Lancet Haematol; 2019 Dec; 6(12):e630-e637. PubMed ID: 31537486
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
Eichenauer DA; La Rosée P
Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study in a Belgian Teaching Hospital.
Yildiz H; Castanares-Zapatero D; d'Abadie P; Bailly S; Yombi JC
Int J Gen Med; 2022; 15():8111-8120. PubMed ID: 36389021
[TBL] [Abstract][Full Text] [Related]
8. A Case Report of Aggressive Post-Infectious Hemophagocytic Lymphohistiocytosis in an Immunocompetent Adult.
Theik NWY
Cureus; 2023 Dec; 15(12):e51334. PubMed ID: 38288192
[TBL] [Abstract][Full Text] [Related]
9. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
10. Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital.
Karlsson T
Ups J Med Sci; 2015; 120(4):257-62. PubMed ID: 26212358
[TBL] [Abstract][Full Text] [Related]
11. Emapalumab for the treatment of hemophagocytic lymphohistiocytosis.
Cheloff AZ; Al-Samkari H
Drugs Today (Barc); 2020 Jul; 56(7):439-446. PubMed ID: 32648854
[TBL] [Abstract][Full Text] [Related]
12. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children.
Xu XJ; Tang YM
World J Pediatr; 2020 Aug; 16(4):333-340. PubMed ID: 31506890
[TBL] [Abstract][Full Text] [Related]
13. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
[TBL] [Abstract][Full Text] [Related]
14. Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and meta-analysis.
Tan CJ; Ng ZQ; Bhattacharyya R; Sultana R; Lee JH
Pediatr Blood Cancer; 2023 Mar; 70(3):e30122. PubMed ID: 36579732
[TBL] [Abstract][Full Text] [Related]
15. Practice patterns and outcomes of hemophagocytic lymphohistiocytosis in adults: a 2-decade provincial retrospective review.
Croden J; Bilston L; Taparia M; Grossman J; Sun HL
Ann Hematol; 2022 Oct; 101(10):2297-2306. PubMed ID: 35978181
[TBL] [Abstract][Full Text] [Related]
16. Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review.
Wang S; Wu J; Jing X; Zhang Y; Tang H; Wu J
Hematology; 2019 Dec; 24(1):751-756. PubMed ID: 33138732
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of
Yang X; Lu X; Liu J; Kan Y; Wang W; Zhang S; Liu L; Li J; Yang J
Korean J Radiol; 2022 Apr; 23(4):466-478. PubMed ID: 35289150
[TBL] [Abstract][Full Text] [Related]
18. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
19. Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
Keenan C; Nichols KE; Albeituni S
Front Immunol; 2021; 12():614704. PubMed ID: 33664745
[TBL] [Abstract][Full Text] [Related]
20. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
Yan WL; Yang SL; Zhao FY; Xu XJ
J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
